Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jing-Yin Granule for COVID-19 wind-heat syndrome
ChiCTR2000030255Phase 4Not yet recruiting
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Jing-Yin Granule in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Shanghai University of Traditional Chinese Medicine. Primary endpoints: Clearance rate of main symptoms and Time to disappearance of main symptoms. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
Jing-Yin Granule
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ChiCTR2000030255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030255.